BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30207029)

  • 1. PHLDA1, another PHLDA family protein that inhibits Akt.
    Chen Y; Takikawa M; Tsutsumi S; Yamaguchi Y; Okabe A; Shimada M; Kawase T; Sada A; Ezawa I; Takano Y; Nagata K; Suzuki Y; Semba K; Aburatani H; Ohki R
    Cancer Sci; 2018 Nov; 109(11):3532-3542. PubMed ID: 30207029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma.
    Baldavira CM; Machado-Rugolo J; Prieto TG; Bastos DR; Balancin M; Ab'Saber AM; Yaegashi LB; Souza PC; Farhat C; Takagaki TY; Nagai MA; Capelozzi VL
    J Thorac Dis; 2021 Feb; 13(2):689-707. PubMed ID: 33717542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive value of Pleckstrin homology-like domain, family A family members in breast cancer.
    R Mangone F; Av Valoyes M; G do Nascimento R; Pf Conceição M; R Bastos D; C Pavanelli A; C Soares I; S de Mello E; Nonogaki S; Ab de T Osório C; A Nagai M
    Biomark Med; 2020 Nov; 14(16):1537-1552. PubMed ID: 33179538
    [No Abstract]   [Full Text] [Related]  

  • 4. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.
    Bonatto N; Carlini MJ; de Bessa Garcia SA; Nagai MA
    Cell Adh Migr; 2018 Jan; 12(1):37-46. PubMed ID: 28640659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLD Class Proteins: A Family of New Players in the p53 Network.
    Fuselier TT; Lu H
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt.
    Kawase T; Ohki R; Shibata T; Tsutsumi S; Kamimura N; Inazawa J; Ohta T; Ichikawa H; Aburatani H; Tashiro F; Taya Y
    Cell; 2009 Feb; 136(3):535-50. PubMed ID: 19203586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.
    Marchiori AC; Casolari DA; Nagai MA
    Braz J Med Biol Res; 2008 Jul; 41(7):579-82. PubMed ID: 18641796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleckstrin homology-like domain, family A, member 1 (
    Nagai MA
    Biomed Rep; 2016 Mar; 4(3):275-281. PubMed ID: 26998263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor.
    Murata T; Sato T; Kamoda T; Moriyama H; Kumazawa Y; Hanada N
    Exp Cell Res; 2014 Jan; 320(2):247-57. PubMed ID: 24270013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis.
    Chen Y; Ohki R
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521808
    [No Abstract]   [Full Text] [Related]  

  • 12. Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of Aurora A, TRKB and affects proteins involved in apoptosis and autophagy pathways.
    Durbas M; Horwacik I; Boratyn E; Rokita H
    Int J Oncol; 2016 Aug; 49(2):823-37. PubMed ID: 27278006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
    Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
    J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
    Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
    Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research Progress of Pleckstrin Homology Like Domain Family A Member 1 in Tumor].
    Zhao SB; Ma HJ; Wu ZG; Ling B; Ye GB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):863-867. PubMed ID: 36325784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
    Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
    Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells.
    Xu J; Bi G; Luo Q; Liu Y; Liu T; Li L; Zeng Q; Wang Q; Wang Y; Yu J; Yi P
    J Cancer; 2021; 12(18):5486-5493. PubMed ID: 34405011
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
    Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.